Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Participants must undergo baseline evaluations, including physical measurements, blood tests, glucose screening, and urinalysis, before commencing the program
Circulation 2023;148:1606-35.ArticlePubMed 84
In ATTAIN-MAINTAIN, participants were randomized to a 12 mg dose of once-daily, oral orforglipron (or matching placebo) which was increased every 4 weeks until the randomized maintenance dose of 36 mg or MTD (24 mg or 36 mg) was reached
Those who cannot tolerate injectable GLP-1 medications
US$ 20.53
US$ 23.59
US$ 28.11
US$ 20.91
